# Immunovant (IMVT): value investors who own it | moatshark

1 value investor held Immunovant in their Q3 2026 13F, led by Greenlight Capital. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Greenlight Capital | 0.1% | $3.6m | Unchanged | 2 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/imvt). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.